ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2024

Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China.

Zhen Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.